V-Meds

V-meds is a newly coined phrase referring to vaporized medicine; a new development that moves beyond outdated medical solutions such as Vicks Vaporub, and progresses prescription medicine into the technologically advanced era we live in now. An electronically revolutionised era, where all manner of medicines can be vaporized and inhaled. An era where the hypodermic needle can retire, and painful jabs become a thing of the past.

In 2016 the regulators of the medical world will be taking control of and overseeing e-liquid, e-cigarettes and vaporizers, this making the path to market easier for devices with medical application.

V-meds could soon be sold over the counter in chemists and surgeries, with many brands offering a vaped alternative for treating ailments like influenza and cancer. Vaporizing technology is moving forward at a steady pace with developments in delivery systems making it possible to administer a controlled and measured dose of medicine with each vape.

V-meds: pain relief

Taking traditional tablets such as paracetamol, ibuprofen and aspirin for aches and pains can be a pain in itself; the pills are huge and hard to swallow, they taste fowl if they touch your tongue, and most annoyingly you have to wait up to half an hour to see any effect. The new method of vaporizing medicines, even commonplace painkillers, can eliminate all three of the hassles mentioned above.

A convenient use for the advancement of vaping medicine is the regular use of painkillers, that could now become instantly effective and simple to deliver a specific controlled dose.

V-meds: cannabis

With the emergence of vaporizing technology as an aid to quit smoking tobacco, there was a realization that other substances can be vaped as a healthier, less intrusive way of medicine administration. Take cannabis for example, in its many forms marijuana has been hailed as a natural cure for some diseases and as a natural form of pain relief. Before vaporizing, cannabis would have been taken orally or smoked; you can also eat cannabis, which is not known to harm the body but takes longer to take effect, as it has to be digested.

Most people know that smoking cannabis is harmful, particularly when rolled with tobacco, and that many gases contained in the smoke are harmful and over time can cause other illnesses. Vaping in the form of v-meds offers a healthier alternative to smoking; none of the harmful gases are released when cannabis is vaporized. When cannabis is vaporized it gets into the bloodstream much quicker compared to ingestion, offering a quicker and more targeted form of pain relief.

V-meds: cancer treatment

In the future, v-med applications could include headache and migraine relief, replacing traditional pills and powders. Heating the medicine before administration also creates a whole new avenue of research into flu and cold treatment, could it be that with v-medicine technology we finally find a cure for the common cold?

Cancer treatment is also another particularly important potential application for v-meds, and some of the many drugs taken to combat cancer could be vaped instead of ingested or injected. Anyone who has had cancer treatment or knows someone that has been through the ordeal, knows that swallowing 20+ pills per day can be tough in itself. Vaping some, if not all, of the medicine is a possibility that’s far less taxing for an extremely ill person.

Taking cannabis oils as a treatment for cancer is a method that some people swear by, vaping the cannabis oil makes this method much less harmful compared to burning and smoking the oils. More and more people are trying alternative treatments, and providing sufferers with a safer means of administering treatments is something pharmaceutical manufacturers should be making a priority.

Medicinal E-liquid

Medicinal e-liquid, nicotine-free e-liquid, administered via an electronic vaping device, is next on the agenda for the think-tanks of the e-smoking industry. Vapeable medicines to treat all manner of ailments are set to revolutionise not only the e-smoking industry, but pharmacology as well.

What we are witnessing currently is a titanic battle between two real super powers: pharmacological corporations, that effect the decisions of governments and push laws through to suit their fields of involvement, and the titans of the tobacco trade whose power and influence far outreaches the mere cigarette between your fingers. The tobacco giants are involved in a complexly intertwined world of regulatory back-scratching with high-level government and adjusted tax levels supposedly in the public’s best interest. So will medicinal e-liquid be any different?

No medicine licence for tobacco firms

It’s not news that tobacco smoking has been targeted with tougher regulations, which have been pushed through by many governments globally in recent years. The banning of smoking in public places has had a social impact and in many cases created a shift in attitude towards tobacco puffers.The trend of harsher regulations suggests that tobacco companies will not be granted a medicinal licence to allow them to trade in e-smoking products.

The e-smoking industry at first was a major threat to tobacco companies, who had been operating successfully and untouched for years. The tobacco firms combated that initial threat by themselves investing heavily in the new electronic smoking industry. However, the move to medical-grade equipment, regulated under the strict and watchful eye of the government and medical officials, will be a change that tobacco companies will struggle to adapt to.

Pharmaceutical E-liquid

Although no information has been released about who will be able to produce pharmaceutical e-liquid post-2016 regulation, it has been announced that any company that wishes to produce and distribute e-liquid must operate under a medicinal licence. Companies that already hold a medicine licence need not worry. This could lead to tobacco companies trying to purchase smaller pharmaceutical companies in a bid to secure themselves a position in this newly heavily-regulated industry.

Actions like this have been seen in the past and are not uncommon nor illegal, it is highly likely that tobacco firms will take this measure to try and steal their share of the market. Whether the MHRA and other regulators allow this to happen, the issuing of medicine licences to tobacco firms will be one that’s contentious and no-doubt contested by the medical world and healthcare professionals. Only the future will tell and time will display the results.